Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,121 | -13,000 | -11,506 | -15,016 | -8,811 |
| Depreciation Amortization | 618 | 637 | 657 | 651 | 478 |
| Accounts receivable | -8 | -25 | 5 | 50 | -42 |
| Accounts payable and accrued liabilities | 106 | 243 | -451 | 504 | -287 |
| Other Working Capital | -72 | 1,894 | 794 | 2,536 | -3,294 |
| Other Operating Activity | 1,682 | 5,052 | 3,454 | 3,813 | 1,156 |
| Operating Cash Flow | $-4,795 | $-5,199 | $-7,047 | $-7,462 | $-10,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 154 | -154 | N/A | 5,081 |
| PPE Investments | -72 | -94 | 228 | -207 | -1,423 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -149 |
| Purchase Sale Intangibles | -370 | -377 | -309 | -535 | -122 |
| Other Investing Activity | -370 | -377 | -309 | -535 | -122 |
| Investing Cash Flow | $-442 | $-317 | $-235 | $-742 | $3,387 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 530 |
| Debt Repayment | -3 | -3 | -3 | -3 | N/A |
| Common Stock Issued | 4,454 | 3,527 | 103 | 4,145 | 14,158 |
| Financing Cash Flow | $4,451 | $3,524 | $100 | $4,142 | $14,688 |
| Exchange Rate Effect | -7 | -6 | -82 | -26 | 15 |
| Beginning Cash Position | 1,198 | 3,196 | 10,460 | 14,548 | 7,258 |
| End Cash Position | 405 | 1,198 | 3,196 | 10,460 | 14,548 |
| Net Cash Flow | $-793 | $-1,998 | $-7,264 | $-4,088 | $7,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,795 | -5,199 | -7,047 | -7,462 | -10,800 |
| Capital Expenditure | -112 | -138 | -310 | -236 | -1,470 |
| Free Cash Flow | -4,907 | -5,337 | -7,357 | -7,698 | -12,270 |